| Literature DB >> 35115019 |
Pengcheng Zhao1,2, Lin Lin2, Mozheng Wu3, Lili Wang2,4, Qi Geng2,4, Li Li2, Ning Zhao2, Jianyu Shi5, Cheng Lu6.
Abstract
BACKGROUND: Chinese herbal medicine is made up of hundreds of natural drug molecules and has played a major role in traditional Chinese medicine (TCM) for several thousand years. Therefore, it is of great significance to study the target of natural drug molecules for exploring the mechanism of treating diseases with TCM. However, it is very difficult to determine the targets of a fresh natural drug molecule due to the complexity of the interaction between drug molecules and targets. Compared with traditional biological experiments, the computational method has the advantages of less time and low cost for targets screening, but it remains many great challenges, especially for the molecules without social ties.Entities:
Keywords: Cosine-correlation; Fresh natural drug molecule; Similarity-comparison; Targets screening; Western-Blot
Mesh:
Substances:
Year: 2022 PMID: 35115019 PMCID: PMC8812203 DOI: 10.1186/s12967-022-03279-w
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
The statistics of the four datasets of gold standard data
| NR | EN | GPCR | IC | |
|---|---|---|---|---|
| Numbers of Targets | 26 | 664 | 95 | 204 |
| Numbers of Drugs | 54 | 445 | 223 | 210 |
| Numbers of Interactions | 90 | 2926 | 635 | 1476 |
| Sparsity(%) | 93.59 | 99.01 | 97.00 | 96.55 |
Fig. 1The overall architecture of CSLN [1]. Get the molecular fingerprint through MACCSkeys based on Rdkit; [2] Tanimoto was used to calculate the similarity between two molecules; [3] w1 is a globally shared value trained from the training dataset
Fig. 2The optimal thresholds for each training set in the tenfold-cross-validation
Fig. 3The performance comparison of DTI prediction across four datasets between CSLN and GRGMF
Fig. 4Experimental result of Western blot (*p < 0.05). a is the chemical formula for triptolide. b is the result of Western-Blot to verify the effect of triptolide on the expression of NQO2 in the L02 hepatocyte. c is the result of one-way ANOVA between the control group (NC) and the experimental group (Triptolide)
Details of the TCMSP data
| Original | Reconstructed | |
|---|---|---|
| Numbers of ingredients | 6494 | 6493 |
| Numbers of targets | 1718 | 1715 |
| Numbers of interactions | 54,852 | 54,818 |
Top 20 targets of the binding score with triptolide
| Name of the target | Source | |
|---|---|---|
| 1 | Proto-oncogene c-Fos | TCMSP |
| 2 | Interleukin-6 | [ |
| 3 | Tumor necrosis factor | TCMSP |
| 4 | Apoptosis regulator BAX | [ |
| 5 | Vascular endothelial growth factor A | TCMSP |
| 6 | Apoptosis regulator Bcl-2 | TCMSP |
| 7 | Caspase-3 | TCMSP |
| 8 | Gamma-aminobutyric-acid receptor subunit alpha-4 | [ |
| 9 | NRH dehydrogenase [quinone] 2 | – |
| 10 | Matrix metalloproteinase-9 | Stitch |
| 11 | Glutamate receptor 2 | – |
| 12 | Transcription factor AP-1 | TCMSP |
| 13 | Transcription factor p65 | TCMSP |
| 14 | Ig gamma-1 chain C region | – |
| 15 | Glucocorticoid receptor | Stitch |
| 16 | Gamma-aminobutyric-acid receptor alpha-5 subunit | – |
| 17 | Neuronal acetylcholine receptor subunit alpha-2 | [ |
| 18 | Neuronal acetylcholine receptor subunit alpha-7 | – |
| 19 | Gamma-aminobutyric-acid receptor alpha-3 subunit | – |
| 20 | Muscarinic acetylcholine receptor M2 | – |